Skip to Content

Green Hygienics Holdings Inc GRYN

Morningstar Rating
$0.00 0.00 (99.83%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GRYN is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$5.72
Uncertainty
Extreme
1-Star Price
$2.65
5-Star Price
$7.66
Economic Moat
Jhjg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GRYN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.15 / $0.19
Market Cap
$44.48
Volume/Avg
1,450 / 3,493

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Green Hygienics Holdings Inc is a full-scope, science-driven, hemp cultivation and branding enterprise focused on the cultivation and processing of industrial hemp for cannabidiol. The company's business includes generating revenues from the sale of hemp and CBD products; creating trusted global consumer brands; developing valuable IP; and growing the company rapidly through strategic acquisitions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
20

Valuation

Metric
GRYN
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
GRYN

Financial Strength

Metric
GRYN
Quick Ratio
0.00
Current Ratio
0.03
Interest Coverage
−4.47
Quick Ratio
GRYN

Profitability

Metric
GRYN
Return on Assets (Normalized)
−67.83%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−205.05%
Return on Assets
GRYN
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
BdygftnldTvnb$82.5 Bil
Merck KGaA ADR
MKKGY
JrfndkkbplVwldzbv$73.2 Bil
Haleon PLC ADR
HLN
KncxxfgjyPcq$41.0 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
ZgmzqwxfDstn$19.2 Bil
Viatris Inc
VTRS
NvcmzgjwVgtc$14.0 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
GywpyyjzzWdqj$13.7 Bil
Catalent Inc
CTLT
HxxyjhjlqLmnzw$10.6 Bil
Perrigo Co PLC
PRGO
GtqybnzzkBrxqv$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
KdtfjbgmSksylwn$3.5 Bil
Curaleaf Holdings Inc
CURLF
DsfjvllVbhy$3.0 Bil

Sponsor Center